MERS in South Korea - Death Toll Continues to Rise

Published On 2015-06-17 05:24 GMT   |   Update On 2015-06-17 05:24 GMT

On Monday, another patient succumbed to the deadly Middle East respiratory syndrome in South Korea, raising the death toll to 16. As of date, 150 people have been diagnosed with MERS, and 17 of them are said to be ‘unstable’.Meanwhile the virus continues to spread, despite stringent measures to impede its transmission. Authorities have quarantined over 5200 people. Officials say this...

Login or Register to read the full article
On Monday, another patient succumbed to the deadly Middle East respiratory syndrome in South Korea, raising the death toll to 16. As of date, 150 people have been diagnosed with MERS, and 17 of them are said to be ‘unstable’.

Meanwhile the virus continues to spread, despite stringent measures to impede its transmission. Authorities have quarantined over 5200 people. Officials say this number may rise in the future.

The World Health Organisation has decided to hold emergency talks on Tuesday to address the outbreak. Addressing the worries that the virus in the Republic of Korea might have mutated to increase its ability to spread, WHO revealed that genome sequencing revealed no such change.

Schools across South Korea are set to reopen this week after having been closed down earlier this month to combat the virus. Over 440 schools will remain closed.

Meanwhile, South Korean President Park Geun-hye urges industries to continue business as usual to combat the stall in the country’s economy.

The source of the outbreak has been traced back to a 68-year old man who returned from a trip to the Middle East on May 20.
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News